HMG CoA reductase inhibitors
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
ATORVASTATIN CALCIUM: products 41 to 60 of 99.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Jamp-Atorvastatin 10mg TabDIN 02391058 | General benefit | $0.1743per source unit | Requirements & sourcesBuild cost plan |
| Jamp-Atorvastatin 20mg TabDIN 02391066 | General benefit | $0.2179per source unit | Requirements & sourcesBuild cost plan |
| Jamp-Atorvastatin 40mg TabDIN 02391074 | General benefit | $0.2342per source unit | Requirements & sourcesBuild cost plan |
| Jamp-Atorvastatin 80mg TabDIN 02391082 | General benefit | $0.2342per source unit | Requirements & sourcesBuild cost plan |
| Lipitor 10mg TabDIN 02230711 | General benefit | $0.1743per source unit | Requirements & sourcesBuild cost plan |
| Lipitor 20mg TabDIN 02230713 | General benefit | $0.2179per source unit | Requirements & sourcesBuild cost plan |
| Lipitor 40mg TabDIN 02230714 | General benefit | $0.2342per source unit | Requirements & sourcesBuild cost plan |
| Lipitor 80mg TabDIN 02243097 | General benefit | $0.2342per source unit | Requirements & sourcesBuild cost plan |
| M-Atorvastatin 10mg TabDIN 02471167 | General benefit | $0.1743per source unit | Requirements & sourcesBuild cost plan |
| M-Atorvastatin 20mg TabDIN 02471175 | General benefit | $0.2179per source unit | Requirements & sourcesBuild cost plan |
| M-Atorvastatin 40mg TabDIN 02471183 | General benefit | $0.2342per source unit | Requirements & sourcesBuild cost plan |
| M-Atorvastatin 80mg TabDIN 02471191 | General benefit | $0.2342per source unit | Requirements & sourcesBuild cost plan |
| Mar-Atorvastatin 10mg TabDIN 02454017 | General benefit | $0.1743per source unit | Requirements & sourcesBuild cost plan |
| Mar-Atorvastatin 20mg TabDIN 02454025 | General benefit | $0.2179per source unit | Requirements & sourcesBuild cost plan |
| Mar-Atorvastatin 40mg TabDIN 02454033 | General benefit | $0.2342per source unit | Requirements & sourcesBuild cost plan |
| Mar-Atorvastatin 80mg TabDIN 02454041 | General benefit | $0.2342per source unit | Requirements & sourcesBuild cost plan |
| Mint-Atorvastatin 10mg TabDIN 02479508 | General benefit | $0.1743per source unit | Requirements & sourcesBuild cost plan |
| Mint-Atorvastatin 20mg TabDIN 02479516 | General benefit | $0.2179per source unit | Requirements & sourcesBuild cost plan |
| Mint-Atorvastatin 40mg TabDIN 02479524 | General benefit | $0.2342per source unit | Requirements & sourcesBuild cost plan |
| Mint-Atorvastatin 80mg TabDIN 02479532 | General benefit | $0.2342per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
Products assigned to this ATC category in the held Health Canada records. Combinations assigned to other categories are not included; search their ingredient or product name separately.
C10AA HMG CoA reductase inhibitors. Health Canada DPD extract 2026-09-02.
WHO Collaborating Centre for Drug Statistics Methodology, ATC/DDD Index, 2026-01-20
C10AA HMG CoA reductase inhibitors